Tech giants partner with US govt to provide resources for COVID-19 research

From volunteering to manufacturing masks and ventilators to ramping up production of essential medical supplies and general items, the country's private sector have joined America's war against coronavirus in a big way, Trump said on Sunday, while launching a new public-private consortium organised by the White House, the Department of Energy and tech company IBM.

PTI

March 23, 2020 / 09:23 IST

US-based global tech giants, including IBM, Amazon, Google and Microsoft, have partnered with the White House to "unleash the power of American supercomputing resources" for combating the novel coronavirus, President Donald Trump has said.

From volunteering to manufacturing masks and ventilators to ramping up production of essential medical supplies and general items, the country's private sector have joined America's war against coronavirus in a big way, Trump said on Sunday, while launching a new public-private consortium organised by the White House, the Department of Energy and tech company IBM.

"The outpouring from the private sector (in the fight against coronavirus) has been extraordinary," he said

The public-private consortium will "unleash the power of American super computing resources" to fight the deadly viral infection, the president said.

IBM, Amazon, Google, Microsoft, MIT, Rensselaer Polytechnic Institute, Department of Energy's National Laboratories, the National Science Foundation and the NASA will be primarily computing resources to help researchers discover new treatments and vaccines.

COVID-19 Vaccine

Frequently Asked Questions

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

Show